Compare Stocks: DYNT, TNON, VRAX, and VVOS

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
DYNT Dynatronics		$0.01	$0.04 ▼ $0.19	$653K	0.31	1,976 shs	N/A
TNON Tenon Medical	$3.02 +2.2%	$5.52	$2.40 ▼ $50.40	$2.03M	1.36	1.96 million shs	1.64 million shs
VRAX Virax Biolabs Group	$2.36 -3.3%	$2.87	$2.14 ▼ $21.75	$1.89M	1.37	1.04 million shs	12,034 shs
VVOS Vivos Therapeutics	$0.14 -3.1%	$0.28	$0.14 ▼ $3.45	$1.96M	6.04	4.54 million shs	499,012 shs

7 Best Space Stocks to Own in 2026

The space race is growing fast, and you don’t have to have gotten in early on SpaceX to profit. This report shows seven space stocks you can buy today that may grow as rockets, satellites, defense, space internet, and new space technology become more important.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
DYNT Dynatronics	0.00%	0.00%	0.00%	0.00%	-86.80%
TNON Tenon Medical	-9.48%	-29.52%	-47.33%	-83.48%	-92.89%
VRAX Virax Biolabs Group	-3.02%	-3.56%	-16.15%	-27.70%	-84.69%
VVOS Vivos Therapeutics	-2.28%	-17.33%	-45.14%	-67.49%	-95.82%

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
DYNT Dynatronics		$0.01	$0.04 ▼ $0.19	$653K	0.31	1,976 shs	N/A
TNON Tenon Medical	$3.02 +2.2%	$5.52	$2.40 ▼ $50.40	$2.03M	1.36	1.96 million shs	1.64 million shs
VRAX Virax Biolabs Group	$2.36 -3.3%	$2.87	$2.14 ▼ $21.75	$1.89M	1.37	1.04 million shs	12,034 shs
VVOS Vivos Therapeutics	$0.14 -3.1%	$0.28	$0.14 ▼ $3.45	$1.96M	6.04	4.54 million shs	499,012 shs

7 Best Space Stocks to Own in 2026

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
DYNT Dynatronics	0.00%	0.00%	0.00%	0.00%	-86.80%
TNON Tenon Medical	-9.48%	-29.52%	-47.33%	-83.48%	-92.89%
VRAX Virax Biolabs Group	-3.02%	-3.56%	-16.15%	-27.70%	-84.69%
VVOS Vivos Therapeutics	-2.28%	-17.33%	-45.14%	-67.49%	-95.82%

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
DYNT Dynatronics	0.00	N/A	N/A	N/A
TNON Tenon Medical	2.00	Hold	N/A	N/A
VRAX Virax Biolabs Group	2.00	Hold	$25.00	959.77% Upside
VVOS Vivos Therapeutics	2.25	Hold	$2.80	1,885.82% Upside

Current Analyst Ratings Breakdown

Latest DYNT, TNON, VRAX, and VVOS Analyst Ratings

Date	Company	Brokerage	Action	Rating
7/17/2026	TNON Tenon Medical	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Sell (E+)
7/17/2026	VVOS Vivos Therapeutics	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Sell (E+)
7/6/2026	VRAX Virax Biolabs Group	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Sell (E+)

(Data available from 9/25/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
DYNT Dynatronics	$33.60M	0.00	N/A	N/A	$0.57 per share	0.00
TNON Tenon Medical	$3.94M	0.51	N/A	N/A	$6.19 per share	0.49
VRAX Virax Biolabs Group	$10K	188.72	N/A	N/A	$42.23 per share	0.06
VVOS Vivos Therapeutics	$17.44M	0.11	N/A	N/A	($0.16) per share	-0.88

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
DYNT Dynatronics	-$2.70M	-$1.35	N/A	N/A	N/A	-8.35%	-41.81%	-9.56%	N/A
TNON Tenon Medical	-$12.56M	-$44.87	N/A	N/A	N/A	-257.85%	-907.60%	-124.84%	11/12/2026 (Estimated)
VRAX Virax Biolabs Group	-$5.02M	N/A	N/A	N/A	N/A	N/A	N/A	N/A	12/2/2026 (Estimated)
VVOS Vivos Therapeutics	-$21.17M	-$1.90	N/A	N/A	N/A	-122.00%	-2,325.64%	-102.01%	11/18/2026 (Estimated)

Latest DYNT, TNON, VRAX, and VVOS Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
8/14/2026	Q2 2026	VVOS Vivos Therapeutics	-$0.41	-$0.31	+$0.10	-$0.31	$5.63 million	$5.15 million
8/13/2026	Q2 2026	TNON Tenon Medical	-$8.40	-$12.35	-$3.95	-$12.35	$1.54 million	$1.28 million
7/3/2026	Q4 2026	VRAX Virax Biolabs Group	-$1.75	-$0.1950	+$1.5550	-$0.1950	$0.00 million	$0.01 million

Compare Dividends

Company	Annual Payout	Dividend Yield	5-Year Annualized Dividend Growth	Payout Ratio	Years of Consecutive Growth
DYNT Dynatronics	N/A	N/A	N/A	N/A	N/A
TNON Tenon Medical	N/A	N/A	N/A	N/A	N/A
VRAX Virax Biolabs Group	N/A	N/A	N/A	N/A	N/A
VVOS Vivos Therapeutics	N/A	N/A	N/A	N/A	N/A

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
DYNT Dynatronics	0.25	1.21	0.60
TNON Tenon Medical	N/A	0.58	0.48
VRAX Virax Biolabs Group	N/A	9.97	9.97
VVOS Vivos Therapeutics	N/A	0.21	0.21

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
DYNT Dynatronics	4.18%
TNON Tenon Medical	22.74%
VRAX Virax Biolabs Group	8.61%
VVOS Vivos Therapeutics	26.35%

Insider Ownership

Company	Insider Ownership
DYNT Dynatronics	2.90%
TNON Tenon Medical	17.71%
VRAX Virax Biolabs Group	45.10%
VVOS Vivos Therapeutics	2.10%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
DYNT Dynatronics	200	16.05 million	8.11 million	Not Optionable
TNON Tenon Medical	26	670,000	549,000	Not Optionable
VRAX Virax Biolabs Group	26	800,000	438,000	Not Optionable
VVOS Vivos Therapeutics	268	13.90 million	13.60 million	Optionable

DYNT, TNON, VRAX, and VVOS Headlines

Recent News About These Companies

Contrasting Inspire Medical Systems (NYSE:INSP) and Vivos Therapeutics (NASDAQ:VVOS)

September 22 at 5:15 AM | americanbankingnews.com

Establishment Labs (NASDAQ:ESTA) vs. Vivos Therapeutics (NASDAQ:VVOS) Head to Head Comparison

September 21, 2026 | americanbankingnews.com

Vivos Therapeutics Announces Material Debt Reduction

September 8, 2026 | globenewswire.com

Vivos Therapeutics to Present at the 2026 Moody Capital Solutions Disruptive Growth & Life Sciences Conference

September 1, 2026 | newsfilecorp.comN

Vivos Therapeutics Advances South Florida Sleep Center With South Palm Cardiovascular Partnership

August 28, 2026 | rttnews.com

Vivos Therapeutics Announces Definitive Agreements With South Palm Cardiovascular Associates to Launch South Florida Sleep & Airway Medicine Center

August 28, 2026 | quiverquant.comQ

Vivos Therapeutics and South Palm Cardiovascular Associates Sign Definitive Agreements to Launch Regional Sleep Testing and Treatment Center

August 28, 2026 | globenewswire.com

Vivos Therapeutics Reports 212% Increase in Nevada Sleep & Airway Medicine Center Referrals Ahead of Henderson Facility Opening

August 25, 2026 | quiverquant.comQ

Vivos Therapeutics Reports Record New Patient Referrals at its Nevada Sleep & Airway Medicine Centers

August 25, 2026 | globenewswire.com

Vivos Therapeutics Opens New Henderson Sleep Center, Expects Capacity to More Than Double to Over $10 Million Annually

August 20, 2026 | quiverquant.comQ

Vivos Therapeutics Opens New Sleep Testing and Treatment Facility in Nevada to Meet Rapidly Growing Patient Demand for Sleep Apnea Testing and Treatment

August 20, 2026 | globenewswire.com

Vivos Therapeutics shares slide after Q2 revenue falls short of forecasts

August 17, 2026 | msn.com

Vivos Therapeutics, Inc: Vivos Therapeutics Reports Second Quarter 2026 Financial Results and Provides Operational Update

August 15, 2026 | finanznachrichten.de

Vivos Therapeutics, Inc. (VVOS) Q2 2026 Earnings Call Transcript

August 14, 2026 | seekingalpha.com

Vivos Therapeutics, Inc. (VVOS) Reports Q2 Loss, Lags Revenue Estimates

August 14, 2026 | zacks.com

Vivos Therapeutics Reports 35% Quarterly Revenue Growth, Rising Patient Demand and Second Quarter 2026 Results

August 14, 2026 | quiverquant.comQ

Vivos Therapeutics Reports Second Quarter 2026 Financial Results and Provides Operational Update

August 14, 2026 | globenewswire.com

Vivos Therapeutics Schedules Release of Second Quarter 2026 Financial Results and Conference Call

August 14, 2026 | globenewswire.com

Vivos Therapeutics Expands Greenway Health Partnership to Deploy AI-Enabled Platform Across All Clinical and Revenue Operations

August 11, 2026 | markets.businessinsider.com

Vivos Therapeutics Expands AI Workflow Partnership with Greenway Health, Citing Up to $9.1 Million in Annual Value at Sleep Centers of Nevada

August 11, 2026 | quiverquant.comQ

New MarketBeat Followers Over Time

Media Sentiment Over Time

DYNT, TNON, VRAX, and VVOS Company Descriptions

Dynatronics NASDAQ:DYNT

Dynatronics Corporation, a medical device company, designs, manufactures, and sells physical therapy, rehabilitation, orthopedics, pain management, and athletic training products in the United States. The company offers orthopedic soft bracing products include cervical collars, shoulder immobilizers, arm slings, wrist and elbow supports, abdominal and lumbosacral supports, maternity supports, knee immobilizers and supports, ankle walkers and supports, plantar fasciitis splints, and cold therapy products. It also offers physical therapy and rehabilitation products, which include therapeutic modality devices comprising electrotherapy, ultrasound, phototherapy, traction, hot and cold therapy, and electrodes; and power and manually operated treatment tables, mat platforms, work tables, parallel bars, training stairs, weight racks, and other related equipment. In addition, the company manufactures and distributes clinical supplies, including exercise bands and tubing, lotions and gels, orthopedic bracings, paper products, and other related supplies. It markets its products under the Dynatron, Dynatron Solaris, Dynaheat, BodyIce, Powermatic, Bird & Cronin, Physician's Choice, Hausmann, PROTEAM, and Mammoth brands. The company sells its products to orthopedists, physical therapists, chiropractors, athletic trainers, sports medicine practitioners, clinics, hospitals, and retail distributors and equipment manufacturers. It also exports its products in Asia, Latin America, and the Middle East. Dynatronics Corporation was founded in 1979 and is headquartered in Eagan, Minnesota.

Tenon Medical NASDAQ:TNON

$3.02 +0.06 (+2.03%)

As of 03:33 PM Eastern

Tenon Medical, Inc., a medical device company, engages in the development of surgical implant systems to treat severe lower back pain in the United States and Puerto Rico. The company offers CATAMARAN SI-Joint Fusion System to fuse sacroiliac joints (SI-Joints) to treat SI-Joint dysfunction that often causes severe lower back pain; and features fixation device that passes through the axial and sagittal planes of the ilium and sacrum, as well as transfixes the SI joints. Tenon Medical, Inc. was incorporated in 2012 and is headquartered in Los Gatos, California.

Virax Biolabs Group NASDAQ:VRAX

$2.36 -0.08 (-3.32%)

As of 03:30 PM Eastern

Virax Biolabs Group Limited, a biotechnology company, sells, distributes, and markets diagnostics test kits for the prevention, detection, diagnosis, and risk management of viral diseases in the field of immunology. The company provides rapid antibody IgC/IgM tests, antigen tests, polymerase chain reaction rapid tests, and neutralizing antibody tests under the ViraxClear brand name. It also develops T-Cell IVD test kit for COVID-19, which intend to adapt for immunological profiling against multiple viral threats under the ViraxImmune Brand, as well as a proprietary mobile application for ViraxImmune that presents an individual's immunological profiling data and provide advice on the users' immune system. It serves clinics, pharmacies, laboratories, hospitals, and other groups, as well as corporations, pharmaceutical companies, research institutions, hospital systems, and public and private institutions. The company operates in Europe, South America, the Asia Pacific, Sub-Saharan Africa, and internationally. The company was formerly known as Virax Biolabs (Cayman) Limited and changed its name to Virax Biolabs Group Limited in September 2021. Virax Biolabs Group Limited was incorporated in 2021 and is headquartered in London, the United Kingdom.

Vivos Therapeutics NASDAQ:VVOS

$0.14 0.00 (-3.09%)

As of 03:21 PM Eastern

Vivos Therapeutics, Inc., a medical technology company, develops and commercializes treatment modalities for patients with dentofacial abnormalities, obstructive sleep apnea (OSA), and snoring in adults. It offers The Vivos Method, a non-invasive, non-surgical, non-pharmaceutical, multi-disciplinary treatment modality for the treatment of dentofacial abnormalities, OSA, and snoring. The company also offers VivoScore Program, a screening and home sleep test in adults and children. It markets and sells its appliances, and related treatments and services to licensed professionals, primarily general dentists in the United States and Canada. Vivos Therapeutics, Inc. was founded in 2016 and is based in Littleton, Colorado.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest DYNT, TNON, VRAX, and VVOS Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest DYNT, TNON, VRAX, and VVOS Earnings

Compare Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

DYNT, TNON, VRAX, and VVOS Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

DYNT, TNON, VRAX, and VVOS Company Descriptions

Dynatronics NASDAQ:DYNT

Tenon Medical NASDAQ:TNON

Virax Biolabs Group NASDAQ:VRAX

Vivos Therapeutics NASDAQ:VVOS

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest DYNT, TNON, VRAX, and VVOS Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest DYNT, TNON, VRAX, and VVOS Earnings

Compare Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

DYNT, TNON, VRAX, and VVOS Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

DYNT, TNON, VRAX, and VVOS Company Descriptions

Dynatronics NASDAQ:DYNT

Tenon Medical NASDAQ:TNON

Virax Biolabs Group NASDAQ:VRAX

Vivos Therapeutics NASDAQ:VVOS

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools